Windham Venture Partners logo

Windham Venture Partners

North America, New York, United States, New York

Description

Windham Venture Partners, established in 2006 and based in New York City, is a dedicated venture capital firm with a clear focus on the healthcare sector. The firm targets early to growth-stage companies that are poised to disrupt or significantly improve various facets of healthcare delivery and management. Their investment scope is broad within healthcare, encompassing innovative digital health solutions, advanced medical devices, precise diagnostics, and tech-enabled services designed to enhance efficiency and patient outcomes. Windham seeks out companies that not only possess groundbreaking technology but also demonstrate strong market potential and are led by experienced and visionary management teams.

The firm's investment philosophy centers on identifying and nurturing companies that can drive meaningful change in the healthcare landscape. They are known for their hands-on approach, actively partnering with their portfolio companies to provide strategic guidance, operational support, and access to their extensive network of industry experts and healthcare stakeholders. This collaborative model aims to accelerate growth, navigate complex regulatory environments, and facilitate market adoption for their portfolio companies, ultimately contributing to their long-term success and impact.

Windham Venture Partners typically deploys initial investments ranging from $2 million to $10 million, reflecting their commitment to supporting companies through critical early and growth phases. This capital is often complemented by follow-on investments as companies achieve key milestones and demonstrate further potential. The firm has successfully raised multiple funds, underscoring its consistent presence and capacity in the healthcare venture ecosystem. For instance, their Windham Venture Partners IV fund closed at $161 million in 2021, following their Windham Venture Partners III fund which closed at $100 million in 2017, demonstrating a strong track record of capital deployment and investor confidence.

Windham's deep specialization in healthcare, combined with its strategic investment approach and substantial capital base, positions it as a significant partner for entrepreneurs aiming to innovate within this vital industry. Their long-standing presence since 2006 and their focus on high-impact solutions make them a notable player in the healthcare venture capital landscape.

Investor Profile

Windham Venture Partners has backed more than 57 startups, with 1 new investments in the last 12 months alone. The firm has led 6 rounds, about 11% of its total and boasts 10 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series Unknown, Series C rounds (top funding stages).
  • Majority of deals are located in United States, Israel.
  • Strong thematic focus on Health Care, Biotechnology, Medical.
  • Led 1 rounds in the past year.
  • Typical check size: $2M – $10M.

Stage Focus

  • Series B (33%)
  • Series Unknown (19%)
  • Series C (16%)
  • Series A (12%)
  • Series D (9%)
  • Series E (4%)
  • Debt Financing (2%)
  • Seed (2%)
  • Convertible Note (2%)
  • Series G (2%)

Country Focus

  • United States (98%)
  • Israel (2%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Health Diagnostics
  • Wellness
  • Artificial Intelligence (Ai)
  • Mhealth
  • Information Technology
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Windham Venture Partners frequently co-invest with?

New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 13
Northpond Ventures
North America, Maryland, United States, Bethesda
Co-Investments: 4
Norwest Venture Partners
North America, California, United States, Palo Alto
Co-Investments: 4
Vertex Ventures HC
North America, California, United States, Palo Alto
Co-Investments: 7
Vertex Ventures
Asia, Central Region, Singapore, Singapore
Co-Investments: 4
AV8 Ventures
North America, California, United States, Palo Alto
Co-Investments: 5
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 4
Medtronic
North America, Minnesota, United States, Minneapolis
Co-Investments: 3
Action Potential Venture Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 5
F8
North America, Colorado, United States, Boulder
Co-Investments: 4

Which angels does Windham Venture Partners often collaborate with?

AL
North America, California, United States, San Francisco
Shared Deals: 1
TK
North America, California, United States, San Francisco
Shared Deals: 1
PB
North America, California, United States, Mountain View
Shared Deals: 1
SC
North America, District of Columbia, United States, Washington
Shared Deals: 1
JH
North America, California, United States, San Francisco
Shared Deals: 1
TI
North America, California, United States
Shared Deals: 1
Shared Deals: 1
AK
North America, California, United States, San Francisco
Shared Deals: 1
KV
North America, New York, United States, New York
Shared Deals: 1
SA
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Windham Venture Partners?

TailorMed

Tel Aviv, Tel Aviv, Israel

Reinventing financial navigation

Financial ServicesFinTechFitnessHealth CareMachine LearningWellness
Series BNov 21, 2024
Amount Raised: $27,500,000
NeuSpera Medical

San Jose, California, United States

NeuSpera Medical is a manufacturing firm that designs, manufactures, and sells implantable neuromodulation medical devices.

Machinery ManufacturingMedical DeviceProduct Design
Series DJul 15, 2024
Amount Raised: $23,000,000
Alto Neuroscience

Los Altos, California, United States

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Artificial Intelligence (AI)BiopharmaBiotechnologyNeurosciencePrecision Medicine
Series CNov 21, 2023
Amount Raised: $45,000,000
Clever Care Health Plan Inc.

Huntington Beach, California, United States

Clever Care Health Plan is a healthcare company that offers medicare advantage health plans to its members.

Health CareHealth InsuranceInsurance
Series CMar 15, 2023
Amount Raised: $42,000,000
Alto Neuroscience

Los Altos, California, United States

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Artificial Intelligence (AI)BiopharmaBiotechnologyNeurosciencePrecision Medicine
Series BOct 25, 2022
Amount Raised: $35,000,000
SubjectWell

Austin, Texas, United States

SubjectWell is the risk-free clinical trials marketplace for patient recruitment

Clinical TrialsHealth CareMarketplaceMedicalPharmaceutical
Series BOct 20, 2022
Amount Raised: $35,000,000
Valera Health

Brooklyn, New York, United States

Valera Health is a tech-enabled mental health company delivering inclusive and tailored care.

Health CareMental HealthmHealthWellness
Series UnknownOct 7, 2022
Amount Raised: $45,000,000
Vergent Bioscience

Minneapolis, Minnesota, United States

Vergent Bioscience is a biotech company focusing on the development of tumor-targeted molecular imaging molecules for cancer surgery.

BiotechnologyHealth CareMedicalMedical Device
Series BOct 4, 2022
Amount Raised: $21,500,000
Upward Health

Hauppauge, New York, United States

Upward Health is a home-based medical group specializing in primary medical and behavioral care for individuals with complex needs.

Health CareMedicalService Industry
Series BSep 13, 2022
Delfi Diagnostics

Baltimore, Maryland, United States

Delfi Diagnostics detects cancer early, when it is most curable, using high precision non-invasive blood tests.

Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMedical
Series BJul 18, 2022
Amount Raised: $225,000,000